Table of Content

1 Market Overview of End-Stage Kidney Disease Treatment
1.1 End-Stage Kidney Disease Treatment Market Overview
1.1.1 End-Stage Kidney Disease Treatment Product Scope
1.1.2 End-Stage Kidney Disease Treatment Market Status and Outlook
1.2 Global End-Stage Kidney Disease Treatment Market Size Overview by Region 2018 VS 2022 VS 2034
1.3 Global End-Stage Kidney Disease Treatment Market Size by Region (2018-2034)
1.4 Global End-Stage Kidney Disease Treatment Historic Market Size by Region (2018-2024)
1.5 Global End-Stage Kidney Disease Treatment Market Size Forecast by Region (2024-2034)
1.6 Key Regions, End-Stage Kidney Disease Treatment Market Size (2018-2034)
1.6.1 North America End-Stage Kidney Disease Treatment Market Size (2018-2034)
1.6.2 Europe End-Stage Kidney Disease Treatment Market Size (2018-2034)
1.6.3 Asia-Pacific End-Stage Kidney Disease Treatment Market Size (2018-2034)
1.6.4 Latin America End-Stage Kidney Disease Treatment Market Size (2018-2034)
1.6.5 Middle East & Africa End-Stage Kidney Disease Treatment Market Size (2018-2034)
2 End-Stage Kidney Disease Treatment Market by Type
2.1 Introduction
2.1.1 MK-3866
2.1.2 Pacritinib
2.1.3 Sanguinate
2.1.4 Tesidolumab
2.1.5 Others
2.2 Global End-Stage Kidney Disease Treatment Market Size by Type: 2018 VS 2022 VS 2034
2.2.1 Global End-Stage Kidney Disease Treatment Historic Market Size by Type (2018-2024)
2.2.2 Global End-Stage Kidney Disease Treatment Forecasted Market Size by Type (2024-2034)
2.3 Key Regions Market Size by Type
2.3.1 North America End-Stage Kidney Disease Treatment Revenue Breakdown by Type (2018-2034)
2.3.2 Europe End-Stage Kidney Disease Treatment Revenue Breakdown by Type (2018-2034)
2.3.3 Asia-Pacific End-Stage Kidney Disease Treatment Revenue Breakdown by Type (2018-2034)
2.3.4 Latin America End-Stage Kidney Disease Treatment Revenue Breakdown by Type (2018-2034)
2.3.5 Middle East and Africa End-Stage Kidney Disease Treatment Revenue Breakdown by Type (2018-2034)
3 End-Stage Kidney Disease Treatment Market Overview by Application
3.1 Introduction
3.1.1 Clinic
3.1.2 Hospital
3.1.3 Others
3.2 Global End-Stage Kidney Disease Treatment Market Size by Application: 2018 VS 2022 VS 2034
3.2.1 Global End-Stage Kidney Disease Treatment Historic Market Size by Application (2018-2024)
3.2.2 Global End-Stage Kidney Disease Treatment Forecasted Market Size by Application (2024-2034)
3.3 Key Regions Market Size by Application
3.3.1 North America End-Stage Kidney Disease Treatment Revenue Breakdown by Application (2018-2034)
3.3.2 Europe End-Stage Kidney Disease Treatment Revenue Breakdown by Application (2018-2034)
3.3.3 Asia-Pacific End-Stage Kidney Disease Treatment Revenue Breakdown by Application (2018-2034)
3.3.4 Latin America End-Stage Kidney Disease Treatment Revenue Breakdown by Application (2018-2034)
3.3.5 Middle East and Africa End-Stage Kidney Disease Treatment Revenue Breakdown by Application (2018-2034)
4 End-Stage Kidney Disease Treatment Competition Analysis by Players
4.1 Global End-Stage Kidney Disease Treatment Market Size by Players (2018-2024)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in End-Stage Kidney Disease Treatment as of 2022)
4.3 Date of Key Players Enter into End-Stage Kidney Disease Treatment Market
4.4 Global Top Players End-Stage Kidney Disease Treatment Headquarters and Area Served
4.5 Key Players End-Stage Kidney Disease Treatment Product Solution and Service
4.6 Competitive Status
4.6.1 End-Stage Kidney Disease Treatment Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 BLR Bio LLC
5.1.1 BLR Bio LLC Profile
5.1.2 BLR Bio LLC Main Business
5.1.3 BLR Bio LLC End-Stage Kidney Disease Treatment Products, Services and Solutions
5.1.4 BLR Bio LLC End-Stage Kidney Disease Treatment Revenue (US$ Million) & (2018-2024)
5.1.5 BLR Bio LLC Recent Developments
5.2 CTI BioPharma Corp
5.2.1 CTI BioPharma Corp Profile
5.2.2 CTI BioPharma Corp Main Business
5.2.3 CTI BioPharma Corp End-Stage Kidney Disease Treatment Products, Services and Solutions
5.2.4 CTI BioPharma Corp End-Stage Kidney Disease Treatment Revenue (US$ Million) & (2018-2024)
5.2.5 CTI BioPharma Corp Recent Developments
5.3 F. Hoffmann-La Roche Ltd
5.3.1 F. Hoffmann-La Roche Ltd Profile
5.3.2 F. Hoffmann-La Roche Ltd Main Business
5.3.3 F. Hoffmann-La Roche Ltd End-Stage Kidney Disease Treatment Products, Services and Solutions
5.3.4 F. Hoffmann-La Roche Ltd End-Stage Kidney Disease Treatment Revenue (US$ Million) & (2018-2024)
5.3.5 Novartis AG Recent Developments
5.4 Novartis AG
5.4.1 Novartis AG Profile
5.4.2 Novartis AG Main Business
5.4.3 Novartis AG End-Stage Kidney Disease Treatment Products, Services and Solutions
5.4.4 Novartis AG End-Stage Kidney Disease Treatment Revenue (US$ Million) & (2018-2024)
5.4.5 Novartis AG Recent Developments
5.5 Prolong Pharmaceuticals LLC
5.5.1 Prolong Pharmaceuticals LLC Profile
5.5.2 Prolong Pharmaceuticals LLC Main Business
5.5.3 Prolong Pharmaceuticals LLC End-Stage Kidney Disease Treatment Products, Services and Solutions
5.5.4 Prolong Pharmaceuticals LLC End-Stage Kidney Disease Treatment Revenue (US$ Million) & (2018-2024)
5.5.5 Prolong Pharmaceuticals LLC Recent Developments
5.6 VESSL Therapeutics Ltd
5.6.1 VESSL Therapeutics Ltd Profile
5.6.2 VESSL Therapeutics Ltd Main Business
5.6.3 VESSL Therapeutics Ltd End-Stage Kidney Disease Treatment Products, Services and Solutions
5.6.4 VESSL Therapeutics Ltd End-Stage Kidney Disease Treatment Revenue (US$ Million) & (2018-2024)
5.6.5 VESSL Therapeutics Ltd Recent Developments
6 North America
6.1 North America End-Stage Kidney Disease Treatment Market Size by Country (2018-2034)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe End-Stage Kidney Disease Treatment Market Size by Country (2018-2034)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific End-Stage Kidney Disease Treatment Market Size by Region (2018-2034)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America End-Stage Kidney Disease Treatment Market Size by Country (2018-2034)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa End-Stage Kidney Disease Treatment Market Size by Country (2018-2034)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 End-Stage Kidney Disease Treatment Market Dynamics
11.1 End-Stage Kidney Disease Treatment Industry Trends
11.2 End-Stage Kidney Disease Treatment Market Drivers
11.3 End-Stage Kidney Disease Treatment Market Challenges
11.4 End-Stage Kidney Disease Treatment Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market End-Stage Kidney Disease Treatment Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2034
Table 2. Global End-Stage Kidney Disease Treatment Market Size by Region (2018-2024) & (US$ Million)
Table 3. Global End-Stage Kidney Disease Treatment Market Size Share by Region (2018-2024)
Table 4. Global End-Stage Kidney Disease Treatment Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 5. Global End-Stage Kidney Disease Treatment Forecasted Market Size Share by Region (2024-2034)
Table 6. Global End-Stage Kidney Disease Treatment Market Size (US$ Million) by Type: 2018 VS 2022 VS 2034
Table 7. Global End-Stage Kidney Disease Treatment Market Size by Type (2018-2024) & (US$ Million)
Table 8. Global End-Stage Kidney Disease Treatment Revenue Market Share by Type (2018-2024)
Table 9. Global End-Stage Kidney Disease Treatment Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 10. Global End-Stage Kidney Disease Treatment Revenue Market Share by Type (2024-2034)
Table 11. North America End-Stage Kidney Disease Treatment Revenue by Type (2018-2024) & (US$ Million)
Table 12. North America End-Stage Kidney Disease Treatment Revenue by Type (2024-2034) & (US$ Million)
Table 13. Europe End-Stage Kidney Disease Treatment Revenue by Type (2018-2024) & (US$ Million)
Table 14. Europe End-Stage Kidney Disease Treatment Revenue by Type (2024-2034) & (US$ Million)
Table 15. Asia-Pacific End-Stage Kidney Disease Treatment Revenue by Type (2018-2024) & (US$ Million)
Table 16. Asia-Pacific End-Stage Kidney Disease Treatment Revenue by Type (2024-2034) & (US$ Million)
Table 17. Latin America End-Stage Kidney Disease Treatment Revenue by Type (2018-2024) & (US$ Million)
Table 18. Latin America End-Stage Kidney Disease Treatment Revenue by Type (2024-2034) & (US$ Million)
Table 19. Middle East and Africa End-Stage Kidney Disease Treatment Revenue by Type (2018-2024) & (US$ Million)
Table 20. Middle East and Africa End-Stage Kidney Disease Treatment Revenue by Type (2024-2034) & (US$ Million)
Table 21. Global End-Stage Kidney Disease Treatment Market Size (US$ Million) by Application: 2018 VS 2022 VS 2034
Table 22. Global End-Stage Kidney Disease Treatment Market Size by Application (2018-2024) & (US$ Million)
Table 23. Global End-Stage Kidney Disease Treatment Revenue Market Share by Application (2018-2024)
Table 24. Global End-Stage Kidney Disease Treatment Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 25. Global End-Stage Kidney Disease Treatment Revenue Market Share by Application (2024-2034)
Table 26. North America End-Stage Kidney Disease Treatment Revenue by Application (2018-2024) & (US$ Million)
Table 27. North America End-Stage Kidney Disease Treatment Revenue by Application (2024-2034) & (US$ Million)
Table 28. Europe End-Stage Kidney Disease Treatment Revenue by Application (2018-2024) & (US$ Million)
Table 29. Europe End-Stage Kidney Disease Treatment Revenue by Application (2024-2034) & (US$ Million)
Table 30. Asia-Pacific End-Stage Kidney Disease Treatment Revenue by Application (2018-2024) & (US$ Million)
Table 31. Asia-Pacific End-Stage Kidney Disease Treatment Revenue by Application (2024-2034) & (US$ Million)
Table 32. Latin America End-Stage Kidney Disease Treatment Revenue by Application (2018-2024) & (US$ Million)
Table 33. Latin America End-Stage Kidney Disease Treatment Revenue by Application (2024-2034) & (US$ Million)
Table 34. Middle East and Africa End-Stage Kidney Disease Treatment Revenue by Application (2018-2024) & (US$ Million)
Table 35. Middle East and Africa End-Stage Kidney Disease Treatment Revenue by Application (2024-2034) & (US$ Million)
Table 36. Global End-Stage Kidney Disease Treatment Revenue (US$ Million) by Players (2018-2024)
Table 37. Global End-Stage Kidney Disease Treatment Revenue Market Share by Players (2018-2024)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in End-Stage Kidney Disease Treatment as of 2022)
Table 39. Date of Key Players Enter into End-Stage Kidney Disease Treatment Market
Table 40. Global End-Stage Kidney Disease Treatment Key Players Headquarters and Area Served
Table 41. End-Stage Kidney Disease Treatment Product Solution and Service
Table 42. Global End-Stage Kidney Disease Treatment Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. BLR Bio LLC Basic Information List
Table 45. BLR Bio LLC Description and Business Overview
Table 46. BLR Bio LLC End-Stage Kidney Disease Treatment Products, Services and Solutions
Table 47. Revenue (US$ Million) in End-Stage Kidney Disease Treatment Business of BLR Bio LLC (2018-2024)
Table 48. BLR Bio LLC Recent Developments
Table 49. CTI BioPharma Corp Basic Information List
Table 50. CTI BioPharma Corp Description and Business Overview
Table 51. CTI BioPharma Corp End-Stage Kidney Disease Treatment Products, Services and Solutions
Table 52. Revenue (US$ Million) in End-Stage Kidney Disease Treatment Business of CTI BioPharma Corp (2018-2024)
Table 53. CTI BioPharma Corp Recent Developments
Table 54. F. Hoffmann-La Roche Ltd Basic Information List
Table 55. F. Hoffmann-La Roche Ltd Description and Business Overview
Table 56. F. Hoffmann-La Roche Ltd End-Stage Kidney Disease Treatment Products, Services and Solutions
Table 57. Revenue (US$ Million) in End-Stage Kidney Disease Treatment Business of F. Hoffmann-La Roche Ltd (2018-2024)
Table 58. F. Hoffmann-La Roche Ltd Recent Developments
Table 59. Novartis AG Basic Information List
Table 60. Novartis AG Description and Business Overview
Table 61. Novartis AG End-Stage Kidney Disease Treatment Products, Services and Solutions
Table 62. Revenue (US$ Million) in End-Stage Kidney Disease Treatment Business of Novartis AG (2018-2024)
Table 63. Novartis AG Recent Developments
Table 64. Prolong Pharmaceuticals LLC Basic Information List
Table 65. Prolong Pharmaceuticals LLC Description and Business Overview
Table 66. Prolong Pharmaceuticals LLC End-Stage Kidney Disease Treatment Products, Services and Solutions
Table 67. Revenue (US$ Million) in End-Stage Kidney Disease Treatment Business of Prolong Pharmaceuticals LLC (2018-2024)
Table 68. Prolong Pharmaceuticals LLC Recent Developments
Table 69. VESSL Therapeutics Ltd Basic Information List
Table 70. VESSL Therapeutics Ltd Description and Business Overview
Table 71. VESSL Therapeutics Ltd End-Stage Kidney Disease Treatment Products, Services and Solutions
Table 72. Revenue (US$ Million) in End-Stage Kidney Disease Treatment Business of VESSL Therapeutics Ltd (2018-2024)
Table 73. VESSL Therapeutics Ltd Recent Developments
Table 74. North America End-Stage Kidney Disease Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 75. North America End-Stage Kidney Disease Treatment Market Size by Country (2024-2034) & (US$ Million)
Table 76. Europe End-Stage Kidney Disease Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 77. Europe End-Stage Kidney Disease Treatment Market Size by Country (2024-2034) & (US$ Million)
Table 78. Asia-Pacific End-Stage Kidney Disease Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 79. Asia-Pacific End-Stage Kidney Disease Treatment Market Size by Region (2018-2024) & (US$ Million)
Table 80. Asia-Pacific End-Stage Kidney Disease Treatment Market Size by Region (2024-2034) & (US$ Million)
Table 81. Asia-Pacific End-Stage Kidney Disease Treatment Market Share by Region (2018-2024)
Table 82. Asia-Pacific End-Stage Kidney Disease Treatment Market Share by Region (2024-2034)
Table 83. Latin America End-Stage Kidney Disease Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 84. Latin America End-Stage Kidney Disease Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 85. Latin America End-Stage Kidney Disease Treatment Market Size by Country (2024-2034) & (US$ Million)
Table 86. Middle East & Africa End-Stage Kidney Disease Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 87. Middle East & Africa End-Stage Kidney Disease Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 88. Middle East & Africa End-Stage Kidney Disease Treatment Market Size by Country (2024-2034) & (US$ Million)
Table 89. End-Stage Kidney Disease Treatment Market Trends
Table 90. End-Stage Kidney Disease Treatment Market Drivers
Table 91. End-Stage Kidney Disease Treatment Market Challenges
Table 92. End-Stage Kidney Disease Treatment Market Restraints
Table 93. Research Programs/Design for This Report
Table 94. Key Data Information from Secondary Sources
Table 95. Key Data Information from Primary Sources
List of Figures
Figure 1. Global End-Stage Kidney Disease Treatment Market Size Year-over-Year 2018-2034 & (US$ Million)
Figure 2. Global End-Stage Kidney Disease Treatment Market Size (US$ Million), 2018 VS 2022 VS 2034
Figure 3. Global End-Stage Kidney Disease Treatment Market Share by Regions: 2022 VS 2034
Figure 4. Global End-Stage Kidney Disease Treatment Forecasted Market Size Share by Region (2024-2034)
Figure 5. North America End-Stage Kidney Disease Treatment Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 6. Europe End-Stage Kidney Disease Treatment Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 7. Asia-Pacific End-Stage Kidney Disease Treatment Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 8. Latin America End-Stage Kidney Disease Treatment Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 9. Middle East & Africa End-Stage Kidney Disease Treatment Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 10. Product Picture of MK-3866
Figure 11. Global MK-3866 Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 12. Product Picture of Pacritinib
Figure 13. Global Pacritinib Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 14. Product Picture of Sanguinate
Figure 15. Global Sanguinate Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 16. Product Picture of Tesidolumab
Figure 17. Global Tesidolumab Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 18. Product Picture of Others
Figure 19. Global Others Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 20. Global End-Stage Kidney Disease Treatment Market Size Share by Type: 2022 & 2034
Figure 21. North America End-Stage Kidney Disease Treatment Revenue Market Share by Type (2018-2034)
Figure 22. Europe End-Stage Kidney Disease Treatment Revenue Market Share by Type (2018-2034)
Figure 23. Asia-Pacific End-Stage Kidney Disease Treatment Revenue Market Share by Type (2018-2034)
Figure 24. Latin America End-Stage Kidney Disease Treatment Revenue Market Share by Type (2018-2034)
Figure 25. Middle East and Africa End-Stage Kidney Disease Treatment Revenue Market Share by Type (2018-2034)
Figure 26. Clinic Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 27. Hospital Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 28. Others Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 29. Global End-Stage Kidney Disease Treatment Market Size Share by Application: 2022 & 2034
Figure 30. North America End-Stage Kidney Disease Treatment Revenue Market Share by Application (2018-2034)
Figure 31. Europe End-Stage Kidney Disease Treatment Revenue Market Share by Application (2018-2034)
Figure 32. Asia-Pacific End-Stage Kidney Disease Treatment Revenue Market Share by Application (2018-2034)
Figure 33. Latin America End-Stage Kidney Disease Treatment Revenue Market Share by Application (2018-2034)
Figure 34. Middle East and Africa End-Stage Kidney Disease Treatment Revenue Market Share by Application (2018-2034)
Figure 35. End-Stage Kidney Disease Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 36. Global Top 5 and Top 10 Players End-Stage Kidney Disease Treatment Market Share in 2022
Figure 37. North America End-Stage Kidney Disease Treatment Market Share by Country (2018-2034)
Figure 38. U.S. End-Stage Kidney Disease Treatment Market Size (2018-2034) & (US$ Million)
Figure 39. Canada End-Stage Kidney Disease Treatment Market Size (2018-2034) & (US$ Million)
Figure 40. Germany End-Stage Kidney Disease Treatment Market Size (2018-2034) & (US$ Million)
Figure 41. France End-Stage Kidney Disease Treatment Market Size (2018-2034) & (US$ Million)
Figure 42. U.K. End-Stage Kidney Disease Treatment Market Size (2018-2034) & (US$ Million)
Figure 43. Italy End-Stage Kidney Disease Treatment Market Size (2018-2034) & (US$ Million)
Figure 44. Russia End-Stage Kidney Disease Treatment Market Size (2018-2034) & (US$ Million)
Figure 45. Nordic Countries End-Stage Kidney Disease Treatment Market Size (2018-2034) & (US$ Million)
Figure 46. Asia-Pacific End-Stage Kidney Disease Treatment Market Share by Region (2018-2034)
Figure 47. China End-Stage Kidney Disease Treatment Market Size (2018-2034) & (US$ Million)
Figure 48. Japan End-Stage Kidney Disease Treatment Market Size (2018-2034) & (US$ Million)
Figure 49. South Korea End-Stage Kidney Disease Treatment Market Size (2018-2034) & (US$ Million)
Figure 50. Southeast Asia End-Stage Kidney Disease Treatment Market Size (2018-2034) & (US$ Million)
Figure 51. India End-Stage Kidney Disease Treatment Market Size (2018-2034) & (US$ Million)
Figure 52. Australia End-Stage Kidney Disease Treatment Market Size (2018-2034) & (US$ Million)
Figure 53. Latin America End-Stage Kidney Disease Treatment Market Share by Country (2018-2034)
Figure 54. Mexico End-Stage Kidney Disease Treatment Market Size (2018-2034) & (US$ Million)
Figure 55. Brazil End-Stage Kidney Disease Treatment Market Size (2018-2034) & (US$ Million)
Figure 56. Middle East & Africa End-Stage Kidney Disease Treatment Market Share by Country (2018-2034)
Figure 57. Turkey End-Stage Kidney Disease Treatment Market Size (2018-2034) & (US$ Million)
Figure 58. Saudi Arabia End-Stage Kidney Disease Treatment Market Size (2018-2034) & (US$ Million)
Figure 59. UAE End-Stage Kidney Disease Treatment Market Size (2018-2034) & (US$ Million)
Figure 60. Bottom-up and Top-down Approaches for This Report